Fecha de publicación: -- Fuente: WIPO "biotechnology" The present invention relates to an isolated polynucleotide encoding the antibody that specifically binds EGFR, expression vector comprising the polynucleotide, a host cell. The invention further relates to a humanized anti-EGFR antigen binding molecule (antibody), a pharmaceutical composition comprising thereof, a method for detecting in vivo or in vitro the presence of EGFR in a sample and use of the antigen binding molecule for the manufacture of a medicament for the treatment or prophylaxis of cancer.